ExodusPoint Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $673K | Buy |
|
|||||
|
2024
Q2 | $1.36M | Buy |
|
|||||
|
2024
Q1 | $829K | Buy |
|
|||||
|
2023
Q4 | $806K | Sell |
|
|||||
|
2023
Q3 | $427K | Sell |
|
|||||
|
2023
Q2 | $373K | Sell |
|
|||||
|
2023
Q1 | $325K | Buy |
|
|||||
|
2022
Q4 | $123K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $137K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $81K | Sell |
|
|||||
|
2020
Q4 | $216K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $254K | Buy |
|